NF2 was diagnosed because of neurological complications due to tumour (n = 10; median age 9 ± 3.2 years) in patients without a family history, family screening (n = 4; median age 11 ± 1.2 years), with cutaneous signs (n = 4, median age at diagnosis 12 ± 5.4 years; median age at first signs 7 ± 4.9 years) or ocular signs (n = 3; median age at diagnosis 4 ± 6.4 years; median age at first signs 0.5 ± 0.7 years). Here, NF2 is linked to neoplasm.